Is the adult mouse striatum a hostile host for neural transplant survival?

NeuroReport

Volumn 24, Issue 18, 2013, Pages 1010-1015

  Roberton, Victoria H ^a   Evans, Amy E ^a   Harrison, David J ^a   Precious, Sophie V ^a   Dunnett, Stephen B ^a   Kelly, Claire M ^a,c   Rosser, Anne E ^a,b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Allograft; Desensitization; Human; Immunosuppression; Mouse; Neurodegeneration; Rejection; Transplantation; Xenograft

Indexed keywords

CYCLOSPORIN A;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; CORPUS STRIATUM; DESENSITIZATION; DONOR; EMBRYONIC STEM CELL; EXPERIMENTAL HOST; FEMALE; GANGLION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; MEDIAN EMINENCE; MOUSE; NERVE DEGENERATION; NEURAL STEM CELL TRANSPLANTATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; XENOTRANSPLANTATION;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; CEREBRAL CORTEX; CORPUS STRIATUM; FEMALE; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; HUMANS; MALE; MICE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84889262447     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0000000000000066     Document Type: Article

References (28)

1. Nakao N, Itakura T. Fetal tissue transplants in animal models of Huntington's disease: the effects on damaged neuronal circuitry and behavioral deficits. Prog Neurobiol 2000; 61:313-338. (Pubitemid 30155724)
2. Goldberg YP, Kalchman MA, Metzler M, Nasir J, Zeisler J, Graham R, et al. Absence of disease phenotype and intergenerational stability of the cag repeat in transgenic mice expressing the human Huntington disease transcript. Hum Mol Genet 1996; 5:177-185. (Pubitemid 26036913)
3. Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, Singaraja R, et al. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 1999; 23:181-192. (Pubitemid 29262475)
4. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996; 87:493-506. (Pubitemid 26374323)
5. Reddy PH, Williams M, Charles V, Garrett L, Pike-Buchanan L, Whetsell WO Jr, et al. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat Genet 1998; 20:198-202. (Pubitemid 28455456)
6. von Hörsten S, Schmitt I, Nguyen HP, Holzmann C, Schmidt T, Walther T, et al. Transgenic rat model of Huntington's disease. Hum Mol Genet 2003; 12:617-624. (Pubitemid 36372488)
7. Zheng S, Geghman K, Shenoy S, Li C. Retake the center stage - new development of rat genetics. J Genet Genomics 2012; 39:261-268.
8. Dunnett SB, Carter RJ, Watts C, Torres EM, Mahal A, Mangiarini L, et al. Striatal transplantation in a transgenic mouse model of Huntington's disease. Exp Neurol 1998; 154:31-40. (Pubitemid 28553564)
9. El-Akabawy G, Rattray I, Johansson SM, Gale R, Bates G, Modo M. Implantation of undifferentiated and pre-differentiated human neural stem cells in the R6/2 transgenic mouse model of Huntington's disease. BMC Neurosci 2012; 13:97.
10. Kelly CM, Precious SV, Scherf C, Penketh R, Amso NN, Battersby A, et al. Neonatal desensitization allows long-term survival of neural xenotransplants without immunosuppression. Nat Methods 2009; 6:271-273.
11. Singhal S, Bhatia B, Jayaram H, Becker S, Jones MF, Cottrill PB, et al. Human Müller glia with stem cell characteristics differentiate into retinal ganglion cell (RGC) precursors in vitro and partially restore RGC function in vivo following transplantation. Stem Cells Transl Med 2012; 1:188-199.
12. Zhang S, Jiang YZ, Zhang W, Chen L, Tong T, Liu W, et al. Neonatal desensitization supports long-term survival and functional integration of human embryonic stem cell-derived mesenchymal stem cells in rat joint cartilage without immunosuppression. Stem Cells Dev 2013; 22:90-101.
13. Kelly CM, Precious SV, Penketh R, Amso N, Dunnett SB, Rosser AE. Striatal graft projections are influenced by donor cell type and not the immunogenic background. Brain 2007; 130:1317-1329. (Pubitemid 47355952)
14. Kelly CM, Precious SV, Torres EM, Harrison AW, Williams D, Scherf C, et al. Medical terminations of pregnancy: a viable source of tissue for cell replacement therapy for neurodegenerative disorders. Cell Transplant 2011; 20:503-513.
15. Billingham RE, Brent L. Acquired tolerance of foreign cells in newborn animals. Proc R Soc Lond B Biol Sci 1956; 146:78-90.
16. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953; 172:603-606.
17. Adkins B, Jones M, Bu Y, Levy RB. Neonatal tolerance revisited again: specific CTL priming in mouse neonates exposed to small numbers of semior fully allogeneic spleen cells. Eur J Immunol 2004; 34:1901-1909. (Pubitemid 39256072)
18. Ridge JP, Fuchs EJ, Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 1996; 271:1723-1726. (Pubitemid 26102819)
19. West LJ, Morris PJ, Wood KJ. Fetal liver haematopoietic cells and tolerance to organ allografts. Lancet 1994; 343:148-149. (Pubitemid 24028643)
20. Modigliani Y, Burlen-Defranoux O, Bandeira A, Coutinho A. Neonatal tolerance to alloantigens is induced by enriched antigen-presenting cells. Scand J Immunol 1997; 46:117-121. (Pubitemid 27323838)
21. Shen Z, Mohiuddin M, DiSesa VJ. Fetal inoculation with donor cells in cardiac xenotransplantation. Ann Thorac Surg 1996; 62:1360-1363. (Pubitemid 26383532)
22. Ando T, Yoshikai Y, Matsuzaki G, Takimoto H, Nomoto K. The stage of negative selection in tolerance induction in neonatal mice. Immunology 1991; 74:638-644.
23. Peiguo Z, Shijie Z, Liang M. Chimerism but not neonatal antigen exposure induces transplant tolerance. Scand J Immunol 2012; 76:108-112.
24. Johann V, Schiefer J, Sass C, Mey J, Brook G, Krüttgen A, et al. Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease. Exp Brain Res 2007; 177:458-470. (Pubitemid 46339598)
25. De Filippis L, Lamorte G, Snyder EY, Malgaroli A, Vescovi AL. A novel, immortal, and multipotent human neural stem cell line generating functional neurons and oligodendrocytes. Stem Cells 2007; 25:2312-2321. (Pubitemid 47480490)
26. Liang Y, Agren L, Lyczek A, Walczak P, Bulte JW. Neural progenitor cell survival in mouse brain can be improved by co-transplantation of helper cells expressing bFGF under doxycycline control. Exp Neurol 2013; 247:73-79.
27. Wang S, Bates J, Li X, Schanz S, Chandler-Militello D, Levine C, et al. Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell stem cell 2013; 12:252-264.
28. Espuny-Camacho I, Michelsen KA, Gall D, Linaro D, Hasche A, Bonnefont J, et al. Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo. Neuron 2013; 77:440-456.